Summit Securities Group’s Exelixis EXEL Stock Holding History

Summit Securities Group’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-11	Closed	–	–	462
2013 Q2	$0	Buy	+11	New	+$52	﹤0.01%	602

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Summit Securities Group's EXEL Position: Q3 2013 in Review

Summit Securities Group sold out of Exelixis (EXEL) in Q3 2013, closing a stake of 11 shares.

Summit Securities Group first reported a position in EXEL in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 126 funds tracked by Wall St. Rank hold EXEL as of Q3 2013.

Summit Securities Group reported no remaining Exelixis position as of Q3 2013 after selling out during the quarter.
Summit Securities Group sold 11 Exelixis shares in Q3 2013.
Summit Securities Group first reported a position in Exelixis in Q2 2013 and held it in 1 quarter.
Summit Securities Group's Exelixis position peaked at $0 in Q2 2013.
126 funds tracked by Wall St. Rank held Exelixis as of Q3 2013.

Based on Summit Securities Group's 13F filing for Q3 2013, filed 1 Nov 2013.